You are here: Industry Insights > Japan

News List

Branded digital support for rheumatoid arthritis patients in Japan looks competitive and encouraging expresspharma
April 30, 2020
According to GlobalData’s report, ‘Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027, Japan contributed US$1.9bn to the global RA market sales in 2017, representing 8.0 per cent of total sales across the 8MM*.
Novartis gets Japan’s approval for Zolgensma pharmaceutical-technology
March 20, 2020
Novartis Pharma has received the Japanese Ministry of Health, Labour and Welfare (MHLW) approval for Zolgensma (onasemnogene abeparvovec) to treat spinal muscular atrophy (SMA).
Guide Infrared Donates Infrared Fever Screening System worth $144,000 to Japan prnasia
March 06, 2020
Guide Infrared, a leading Chinese manufacturer of infrared thermal imaging systems based in Wuhan, China, has donated GUIDE IR Fever Warning Systems to Japan.
Rentschler Bio enhances collaboration in Japan biospectrumasia
October 08, 2019
SPI and Rentschler Biopharma are working together with Japanese clients to outline projects from early clinical stage up to commercial launch and ensure optimal service.
AGC Biologics appoints new General Manager for Japan biospectrumasia
September 26, 2019
Kagami-san has the expertise and experience to lead our Chiba site in the growth and achievement of our stated goals and objectives.
Takeda and Lundbeck’s Trintellix approved in Japan for depression pharmaceutical-technology
September 25, 2019
Takeda has announced that its drug Trintellix (vortioxetine) has been approved by the Japanese Ministry of Health, Labour and Welfare for the treatment of depression and depressed state.
Treatment for dialysis patients with CKD anaemia approved in Japan europeanpharmaceuticalreview
September 23, 2019
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
Japan looks out for rapidly growing ASEAN ageing population biospectrumasia
September 04, 2019
In 2030, more than 70 million people in ASEAN are projected to be older than 65 years old
GSK submits first regulatory application for daprodustat in Japan biospectrumasia
August 25, 2019
The JNDA for daprodustat is primarily based on positive data from the phase 3 programme conducted in Japan
Neopharma snaps up Lupin's sterile injectables business in Japan fiercepharma
August 25, 2019
Neopharma, which has been buying and building plants for several years, is at it again. The United Arab Emirates-based drugmaker is buying a sterile injectables plant and drugs in Japan from India’s Lupin.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page